Valuation: Janel Corporation

Market Cap 61.67M 52.93M 49.68M 45.37M 85.63M 5.88B 86.04M 588M 228M 2.97B 232M 227M 9.83B P/E 2024
225x
P/E 2025 8.64x
Enterprise Value 69.28M 59.47M 55.81M 50.98M 96.21M 6.61B 96.67M 661M 256M 3.33B 260M 254M 11.04B EV / Sales 2024
0.46x
EV / Sales 2025 0.24x
Free-Float
17.08%
Yield 2024 *
-
Yield 2025 -
1 day+3.42%
1 week-13.43%
Current month-22.41%
1 month+7.12%
6 months-13.01%
Current year+12.50%
1 month 45
Extreme 45
51.98
Current year 37
Extreme 37
58
1 year 21
Extreme 21
58
3 years 21
Extreme 21
58
5 years 15.51
Extreme 15.51
62
10 years 4.01
Extreme 4.01
62
Manager TitleAgeSince
Chief Executive Officer 52 2022-12-31
Director of Finance/CFO 39 2025-08-01
Chief Executive Officer 52 2014-09-10
Director TitleAgeSince
Director/Board Member 77 2015-11-17
Director/Board Member 76 2016-05-31
Director/Board Member 74 2018-01-01
Date Insider Type Main position Quantity % Market Cap.
6/2/26 Buy

Director

225 0.0190%
5/28/26 Buy

Director

900 0.0759%
10/1/25 Free

Director

2,500 0.2107%
Change 5-day change 1-year change 3-year change Capi.($)
+3.42%-13.43%+12.50%+50.00% 61.67M
-2.25%-3.10%+38.65%-1.87% 83.24B
-5.77%-14.18%+505.18%+33.71% 63.41B
+0.35%+3.93%-19.58%-35.42% 59.49B
+0.76%+3.53%+0.08%+36.18% 52.94B
-1.38%+1.47%+10.64%+170.57% 49.86B
+0.14%-0.22%+61.70%-16.40% 32.62B
-1.23%-0.27%+52.52%+100.63% 26.29B
+9.69%+11.76%+14.67%+224.85% 22.23B
-1.15%-0.30%+60.29%+121.68% 17.22B
Average +0.82%+0.51%+73.67%+68.39% 40.74B
Weighted average by Cap. -0.08%-0.32%+96.67%+47.87%

Financials

2024 2025
Net sales 183M 157M 148M 135M 254M 17.47B 256M 1.75B 677M 8.81B 688M 673M 29.19B 207M 178M 167M 153M 288M 19.79B 289M 1.98B 766M 9.98B 779M 762M 33.06B
Net income 551K 473K 444K 405K 765K 52.55M 769K 5.25M 2.04M 26.51M 2.07M 2.02M 87.81M 5.66M 4.86M 4.56M 4.16M 7.86M 540M 7.89M 53.93M 20.9M 272M 21.24M 20.78M 902M
Net Debt 36.99M 31.75M 29.8M 27.22M 51.36M 3.53B 51.61M 353M 137M 1.78B 139M 136M 5.89B 7.62M 6.54M 6.14M 5.6M 10.58M 726M 10.63M 72.61M 28.14M 366M 28.6M 27.98M 1.21B
Logo Janel Corporation
Janel Corporation is a holding company with subsidiaries in three business segments: Logistics, Life Sciences and Manufacturing. The Company’s Life Sciences segment comprises several wholly owned subsidiaries. The Company’s Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Company’s Manufacturing segment comprises Indco, Inc. (Indco). Indco is a majority-owned subsidiary of the Company that manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Its Logistics segment is a non-asset based, full-service provider of cargo transportation logistics management services including freight forwarding via air, ocean and land-based carriers; customs brokerage services; warehousing and distribution services; trucking and others.
Employees
353
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. JANL Stock